doi: 10.1136/bmjgh-2021-006885 285
Significant Energy Boosts: Experience a noticeable increase in energy levels
Beyond more traditional measures of adjusting the BMI threshold to 35, some plan sponsors have elected to offer coverage for those with comorbidities, where the clinical benefits may be more pronounced (e.g., obstructive sleep apnea, reducing major adverse cardiovascular events or metabolic liver disease)
They were able to stick to it longer
Through these combined actions, enhanced insulin secretion, reduced glucagon, delayed gastric emptying, appetite suppression, and favorable metabolic and cardiovascular effects, semaglutide provides durable glycemic control, substantial weight reduction, and cardiovascular risk reduction in patients with type 2 diabetes and obesity